.Avidity Biosciences impressed financiers along with period 1/2 records in Duchenne muscle dystrophy...
.Actinogen Medical's cortisol blocker has missed the primary endpoint of a period 2 research study i...
.Antibody-drug conjugates (ADCs) have been at the center of several a billion-dollar biobuck licensi...
.Asset manager TPG, which has sustained biotechs including Sionna Rehabs and Santa Clam Ana Bio, has...
.Merck & Co.'s TIGIT program has actually gone through yet another misfortune. Months after shutt...
.After a year described by pipe cuts, the variation of its own CEO and layoffs, Exscientia will comb...
.Cullinan Therapeutics was actually wowed sufficient with Port BioMed's bispecific invulnerable acti...
.Within this week's incident of "The Leading Line," our team're diving into Ferocious Biotech's year...
.The confetti is actually still flying from Eli Lilly's party commemorating the approval of Alzheime...
.Invite to this week's Chutes & Ladders, our roundup of substantial management hirings, shootings...